Literature DB >> 35058620

Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.

.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35058620      PMCID： PMC8922451          DOI： 10.1038/s41591-021-01617-x

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  3 in total

Review 1.  Optimizing the Design and Analysis of Future AKI Trials.

Authors:  Matthieu Legrand; Sean M Bagshaw; Jay L Koyner; Ivonne H Schulman; Michael R Mathis; Juliane Bernholz; Steven Coca; Martin Gallagher; Stéphane Gaudry; Kathleen D Liu; Ravindra L Mehta; Romain Pirracchio; Abigail Ryan; Dominik Steubl; Norman Stockbridge; Fredrik Erlandsson; Alparslan Turan; F Perry Wilson; Alexander Zarbock; Michael P Bokoch; Jonathan D Casey; Patrick Rossignol; Michael O Harhay
Journal:  J Am Soc Nephrol       Date:  2022-07-13       Impact factor: 14.978

2.  New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021.

Authors:  Thomas R Martin; Rachel L Zemans; Lorraine B Ware; Eric P Schmidt; David W H Riches; Lisa Bastarache; Carolyn S Calfee; Tushar J Desai; Susanne Herold; Catherine L Hough; Mark R Looney; Michael A Matthay; Nuala Meyer; Samir M Parikh; Troy Stevens; B Taylor Thompson
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

3.  Aviptadil for COVID-19: A Case Study and Call to Action About the Challenges of Research During a Global Pandemic.

Authors:  Sara C Auld
Journal:  Crit Care Med       Date:  2022-10-13       Impact factor: 9.296
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.